CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Labiotech.eu
Original article

Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe

Positive
AI Analysis

Summary

Merck opens a new BioReliance facility in Darmstadt, Germany to support biologics testing, GMP release testing, and stability studies for European market.

Importance:2/10
Sentiment:
0.50
facilitybiotech infrastructurebiologicsGMP testingEuropeDarmstadt
Related Companies

Read the original article

Published by Labiotech.eu on October 6, 2026 8:00 AM

Read Original